This content is only available within our institutional offering.
10 Apr 2018
Growth Platform
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Growth Platform
hVIVO plc (HVO:LON) | 26.5 -0.1 (-2.0%) | Mkt Cap: 180.3m
- Published:
10 Apr 2018 -
Author:
Chris Donnellan -
Pages:
35
Venn Life Sciences is a full service European Contract Research Organisation serving the pharmaceutical, biotechnology and medical device industries. Venn has stated a strategy of delivering more aggressive revenue growth via both organic and in-organic sources in order to leverage its established operational platform. We expect this strategy to deliver strong profit growth, which at this time is not reflected in the company’s valuation. We initiate coverage with a Buy recommendation.